Anti-CD3 Antibody Induces IL-10-producing CD4+CD25+ Regulatory T Cells, Which Suppress T Cell Response in Rheumatoid Arthritis Patients.
- Author:
Bo Young YOON
1
;
Mi La CHO
;
Yeon Sik HONG
;
Joo Yeon JHUN
;
Mi Kyung PARK
;
Kyung Su PARK
;
Sung Hwan PARK
;
Ho Youn KIM
Author Information
- Publication Type:In Vitro ; Original Article
- Keywords: Regulatory T cells; CD4+CD25+ cell; rheumatoid arthritis; IL-10; peripheral blood
- MeSH: Arthritis, Rheumatoid*; Autoimmune Diseases; Coculture Techniques; Humans; Immune System; Inflammation; Interleukin-10; Interleukins; Phenotype; T-Lymphocytes; T-Lymphocytes, Regulatory*
- From:Immune Network 2007;7(3):124-132
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: Regulatory T cells (Tregs) have been investigated intensively for some decades. These cells regulate the immune system, prevent overactivated immune responses and can be used therapeutically. For rheumatoid arthritis (RA), understanding the functions and status of Tregs is an important step for understanding immune regulation in this autoimmune disease. METHODS: We investigated the percentages, phenotypes and suppressive functions of CD4+CD25+ Tregs in peripheral blood (PB) of patients with RA. RESULTS: The percentages were higher in the patients (n=12) than in healthy controls (n=10), and the cells expressed the CD45RBlow, CTLA-4 and CCR7 phenotypes. We also investigated the expression of Foxp3 and secretion of interleukin (IL)-10 induced CD4+CD25+ Tcells by anti-CD3 antibody treatment. A suppressive function of the patients' cells was shown through coculture with CD4+CD25+ T cells in vitro. CONCLUSION: We suggest that, despite their increased numbers and suppressive function, they manage the ongoing inflammation ineffectively. It might be possible to apply IL-10 to induce the proliferation of IL-10-producing Tregs as therapy for RA.
